newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences

CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and com